Redpin Therapeutics is a privately-held, preclinical stage gene therapy company based in New York City.  We are developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Our approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy.

Pharmaceutical

Redpin Therapeutics

Redpin Therapeutics' headquarters in New York, NY, United States

Description

People

Jobs